Gamida Cell to Participate in Upcoming Investor Conferences

BOSTON--()--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced that company management will participate in three upcoming virtual investor conferences in September:

H.C. Wainwright 22nd Annual Global Investment Conference
Date: Monday, September 14, 2020
Presentation: 11:00 a.m. ET

Cantor Virtual Global Healthcare Conference
Date: Thursday, September 17, 2020
Presentation: 4:00 p.m. ET

Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
Date: Monday, September 21, 2020
Fireside Chat: 4:10 p.m. ET

A live webcast of each presentation will be available in the “Investors & Media” section of the Gamida Cell website, www.gamida-cell.com, and will be available for at least 14 days following the event.

About Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. For additional information, please visit www.gamida-cell.com or follow Gamida Cell on LinkedIn or Twitter at @GamidaCellTx.

Contacts

Jaren Irene Madden
jaren@gamida-cell.com
1-617-286-6264

Matthew Corcoran (media)
mcorcoran@tenbridgecommunications.com
1-617-866-7350

Release Summary

Gamida Cell will participate in three upcoming virtual investor conferences in September.

$Cashtags

Contacts

Jaren Irene Madden
jaren@gamida-cell.com
1-617-286-6264

Matthew Corcoran (media)
mcorcoran@tenbridgecommunications.com
1-617-866-7350